Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Olatz Sagastagoia
Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Letter: Double-Dose Intensification-A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab. Authors Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Antibody Response to a Standard Dose of Hepatitis B Vaccine in HIV-Infected Patients
Klimik Dergisi
Infectious Diseases
Microbiology
Erratum To: Practical Application of Acid Dissociation in Monitoring Patients Treated With Adalimumab
Rheumatology International
Rheumatology
Allergy
Immunology
Response to Letter Regarding Article, "Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting"
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Dose Sparing and the Lack of a Dose-Response Relationship With an Influenza Vaccine in Adult and Elderly Patients - A Randomized, Double-Blind Clinical Trial
British Journal of Clinical Pharmacology
Pharmacology
